Image

Medical Literacy in TIA (Transient Ischemic Attack) Patients

Medical Literacy in TIA (Transient Ischemic Attack) Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

There are around 30,000 TIAs (transient ischemic attacks) per year in France. This pathology can be the warning sign of a stroke, responsible for significant morbidity and mortality at the population level.

An important part of patient care is to teach them to recognize the symptoms suggestive of a stroke as well as the contributing factors, thus improving the medical literacy of patients.

The results of studies that have assessed medical literacy in France and Europe converge towards a rather low level.

Some studies have focused on stroke literacy in France. They show good knowledge of risk factors and the attitude to adopt in the event of a stroke, but recognition of symptoms remains problematic.

There is very little literature concerning knowledge of TIA in the general population and there are no studies concerning literacy in a population having presented with TIA.

The aim of this study is to evaluate the knowledge of patients who have presented with a TIA (and therefore at high cardiovascular risk) about this disease (risk factors, symptoms, severity, attitude to adopt in the event of symptoms), after their visit to the emergency room.

The investigators make the hypothesis that knowledge of TIA and its consequences will be rather low in this population of patient, even after a medical contact at the emergency room.

Eligibility

Inclusion Criteria :

  • Adult men and women ≥18 years old
  • Patient referred to neurology day hospital at the Pierre Wertheimer neurological hospital after first care in the emergency department
  • Patient having been informed and having expressed his non-opposition
  • Patient affiliate to a social security scheme

Exclusion Criteria :

  • Patient unable to complete the questionnaire
  • History of stroke/TIA
  • Patient who do not understand the French language
  • Patient under legal protection, guardianship, curatorship, under judicial protection-

Study details
    Transient Ischemic Attack

NCT07040761

Hospices Civils de Lyon

21 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.